Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer Biotech Investing
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression Psychedelics Investing
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary Biotech Investing
C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society Annual Meeting Biotech Investing
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status Biotech Investing
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger Medical Device Investing
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Biotech Investing
